Abstract
Rheumatoid arthritis (RA) is a destructive polyarthritis in which synovial-like fibroblasts (SFs) invade and erode cartilage by expressing membrane-anchored type 1 matrix metalloproteinase (MT1-MMP). The mitogen activated protein kinase (MAPK) pathway is activated in RA SFs, but the mechanism of activation is unknown. Here we identify aberrant BRAF splice variants with deletions in both the kinase domain and RAS-binding domain (RBD) in SFs from the majority of RA patients and show that these BRAF splice variants constitutively activate MAPK through CRAF, increase expression of MT1-MMP, and enhance fibroblast invasion of collagen. © 2013 .
| Original language | English |
|---|---|
| Pages (from-to) | 247-252 |
| Number of pages | 6 |
| Journal | Molecular Immunology |
| Volume | 55 |
| Issue number | 3-4 |
| DOIs | |
| State | Published - Oct 2013 |
ASJC Scopus Subject Areas
- Immunology
- Molecular Biology
Keywords
- MAPK cascade
- Oncogene
- Rheumatoid arthritis
- NIH 3T3 Cells
- Humans
- Middle Aged
- Recombinant Proteins/genetics
- Arthritis, Rheumatoid/genetics
- Male
- Protein Isoforms/genetics
- Proto-Oncogene Proteins B-raf/chemistry
- Alternative Splicing/immunology
- MAP Kinase Signaling System/immunology
- Animals
- Adult
- Female
- Aged
- Fibroblasts/immunology
- Mice
- Matrix Metalloproteinase 14/metabolism
- Proto-Oncogene Proteins c-raf/genetics
- Synovial Membrane/immunology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS